NEUCHATEL, Switzerland & SHENZHEN, China--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) and Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (SZSE: 300760) announced today that they have entered into a ...
Mindray Medical ($MR) and Masimo ($MASI) are laying their years-long legal battle over pulse oximeter technology to rest, with the companies agreeing to dismiss all ...
Masimo Corp. is sponsoring a new clinical study titled “Philips FAST SpO2 Technology With Masimo Sensors for SpO2 Monitoring in the Neonatal, Infant, and Pediatric Populations.” The goal is to confirm ...
Improved SpO 2 Accuracy Now Available for All Patient Populations IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) announced today that RD SET ® sensors with Masimo Measure-through Motion and ...
With the invention of Signal Extraction Technology ® (SET ®), Masimo established a new standard for pulse oximetry by introducing the ability to measure through motion and low perfusion. In a study ...
Patient monitors now available with integrated Masimo SET ® pulse oximetry include the Mindray BeneVision N and BeneView T series for use in high-acuity environments and the ePM, iPM, and iMEC series ...
Mindray is a leading global provider of medical devices and solutions. Mindray's products and services can be found in healthcare facilities in over 190 countries, and over 1.1 million Mindray ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback